These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27616151)

  • 21. Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy.
    Gross MD; Shapiro B; Freitas JE
    J Nucl Med; 1985 Jan; 26(1):43-8. PubMed ID: 2981301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenal Venous Sampling Is Useful for a Definitive Diagnosis in Cushing's Syndrome with Bilateral Adrenal Tumors.
    Seki T; Yasuda A; Kitajima N; Oki M; Takagi A; Nakamura N; Hanai K; Terachi T; Fukagawa M
    Tokai J Exp Clin Med; 2015 Dec; 40(4):149-56. PubMed ID: 26662665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
    Di Dalmazi G; Vicennati V; Rinaldi E; Morselli-Labate AM; Giampalma E; Mosconi C; Pagotto U; Pasquali R
    Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased ratio of mRNA expression of the genes CYP17 and CYP11B1 indicates autonomous cortisol production in adrenocortical tumors.
    Enberg U; Hennings J; Volpe C; Hellman P; Höög A; Hamberger B; Thorén M
    J Endocrinol Invest; 2009 Nov; 32(10):810-5. PubMed ID: 19564722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of dexamethasone suppression test during the diagnosis of primary pigmented nodular adrenocortical disease in Chinese adrenocorticotropic hormone-independent Cushing syndrome.
    Chen S; Li R; Lu L; Duan L; Zhang X; Tong A; Pan H; Zhu H; Lu Z
    Endocrine; 2018 Jan; 59(1):183-190. PubMed ID: 29094256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between contralateral adrenal and hypothalamus-pituitary-adrenal axis in benign adrenocortical tumors.
    Zhu H; Wu L; Su T; Jiang L; Zhou W; Jiang Y; Zhang C; Zhong X; Wang W
    Front Endocrinol (Lausanne); 2023; 14():1199875. PubMed ID: 37560307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?
    Eller-Vainicher C; Morelli V; Salcuni AS; Torlontano M; Coletti F; Iorio L; Cuttitta A; Ambrosio A; Vicentini L; Carnevale V; Beck-Peccoz P; Arosio M; Ambrosi B; Scillitani A; Chiodini I
    Eur J Endocrinol; 2010 Jan; 162(1):91-9. PubMed ID: 19797503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses.
    Young WF; du Plessis H; Thompson GB; Grant CS; Farley DR; Richards ML; Erickson D; Vella A; Stanson AW; Carney JA; Abboud CF; Carpenter PC
    World J Surg; 2008 May; 32(5):856-62. PubMed ID: 18074172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multicenter study.
    Fagour C; Bardet S; Rohmer V; Arimone Y; Lecomte P; Valli N; Tabarin A
    Eur J Endocrinol; 2009 Feb; 160(2):257-64. PubMed ID: 18974229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study.
    Bonaventura I; Tomaselli A; Angelini F; Ferrari D; De Alcubierre D; Hasenmajer V; Sbardella E; Cozzolino A; Paganini AM; Isidori AM; Minnetti M; Pofi R
    J Endocrinol Invest; 2024 Jul; 47(7):1751-1762. PubMed ID: 38386266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A patient with preclinical Cushing's syndrome and excessive DHEA-S secretion having unilateral adrenal carcinoma and contralateral adenoma.
    Midorikawa S; Hashimoto S; Kuriki M; Katoh K; Watanabe T; Sasano H; Nishikawa T
    Endocr J; 1999 Feb; 46(1):59-66. PubMed ID: 10426568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenal reserve function after unilateral adrenalectomy in patients with primary aldosteronism.
    Honda K; Sone M; Tamura N; Sonoyama T; Taura D; Kojima K; Fukuda Y; Tanaka S; Yasuno S; Fujii T; Kinoshita H; Ariyasu H; Kanamoto N; Miura M; Yasoda A; Arai H; Ueshima K; Nakao K
    J Hypertens; 2013 Oct; 31(10):2010-7. PubMed ID: 23846863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.
    Nunes ML; Vattaut S; Corcuff JB; Rault A; Loiseau H; Gatta B; Valli N; Letenneur L; Tabarin A
    J Clin Endocrinol Metab; 2009 Feb; 94(2):456-62. PubMed ID: 19001518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminative Capacity of CT Volumetry to Identify Autonomous Cortisol Secretion in Incidental Adrenal Adenomas.
    Olmos R; Mertens N; Vaidya A; Uslar T; Fernandez P; Guarda FJ; Zúñiga Á; San Francisco I; Huete A; Baudrand R
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1946-e1953. PubMed ID: 35020922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma.
    La Cava G; Imperiale A; Olianti C; Gheri GR; Ladu C; Mannelli M; Pupi A
    J Nucl Med; 2003 Jul; 44(7):1057-64. PubMed ID: 12843220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenal incidentalomas and subclinical Cushing syndrome: indications to surgery and results in a series of 26 laparoscopic adrenalectomies.
    Pisano G; Calò PG; Erdas E; Pigliaru F; Piras S; Sanna S; Manca A; Dazzi C; Nicolosi A
    Ann Ital Chir; 2015; 86():406-12. PubMed ID: 26567723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term study of subclinical Cushing's syndrome shows high prevalence of extra-adrenal malignancy in patients with functioning bilateral adrenal tumors.
    Kawate H; Kohno M; Matsuda Y; Akehi Y; Tanabe M; Horiuchi T; Ohnaka K; Nomura M; Yanase T; Takayanagi R
    Endocr J; 2014; 61(12):1205-12. PubMed ID: 25223468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenocortical adenoma manifesting as Cushing's syndrome and pseudo-precocious puberty in a toddler.
    Boro H; Kubihal S; Dutta R; Kubihal V; Alam S; Tandon N
    Pediatr Endocrinol Diabetes Metab; 2022; 28(1):81-87. PubMed ID: 35193331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Subclinical Cushing's syndrome in populations at risk].
    Caetano MS; Vilar L; Kater CE
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1185-90. PubMed ID: 18209855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the 1 mg overnight dexamethasone suppression test in the diagnosis of the subclinical Cushing's syndrome in patients with Adrenal Incidentaloma].
    Li L; Han B; Dou J; Yang G; Gu W; Lü Z; Mu Y
    Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(48):3912-6. PubMed ID: 27122212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.